Stxbp4 regulates ΔNp63 stability by suppression of RACK1-dependent degradation

Molecular and Cellular Biology

Volumn 29, Issue 14, 2009, Pages 3953-3963

  Li, Yingchun ^a,b   Peart, Melissa J ^a   Prives, Carol ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P63; PROTEIN STXBP4; RECEPTOR FOR ACTIVATED C KINASE 1; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; GNB2L1 PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPROTEIN; ITCH PROTEIN, HUMAN; REPRESSOR PROTEIN; SMALL INTERFERING RNA; STXBP4 PROTEIN, HUMAN; TP63 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; VESICULAR TRANSPORT PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRESS; CONTROLLED STUDY; DNA DAMAGE; GENOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; AMINO ACID SEQUENCE; CELL AGING; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN ANALYSIS; PROTEIN BINDING; RNA INTERFERENCE; TWO HYBRID SYSTEM;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL AGING; CELL LINE; CELL PROLIFERATION; DNA DAMAGE; GTP-BINDING PROTEINS; HUMANS; KERATINOCYTES; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN ISOFORMS; RECEPTORS, CELL SURFACE; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITIN-PROTEIN LIGASES; VESICULAR TRANSPORT PROTEINS;

EID: 67650088240     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00449-09     Document Type: Article

References (65)

1. Barbieri, C. E., C. E. Barton, and J. A. Pietenpol. 2003. ΔNp63α expression is regulated by the phosphoinositide 3-kinase pathway. J. Biol. Chem. 278:51408-51414.
2. Barbieri, C. E., C. A. Perez, K. N. Johnson, K. A. Ely, D. Billheimer, and J. A. Pietenpol. 2005. IGFBP-3 is a direct target of transcriptional regulation by ΔNp63α in squamous epithelium. Cancer Res. 65:2314-2320.
3. Blanpain, C., and E. Fuchs. 2007. p63: revving up epithelial stem-cell potential. Nat. Cell Biol. 9:731-733.
4. Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771.
5. Candi, E., A. Rufini, A. Terrinoni, D. Dinsdale, M. Ranalli, A. Paradisi, V. De Laurenzi, L. G. Spagnoli, M. V. Catani, S. Ramadan, R. A. Knight, and G. Melino. 2006. Differential roles of p63 isoforms in epidermal development: selective genetic complementation in p63 null mice. Cell Death Differ. 13:1037-1047.
6. Carroll, D. K., J. S. Carroll, C. O. Leong, F. Cheng, M. Brown, A. A. Mills, J. S. Brugge, and L. W. Ellisen. 2006. p63 regulates an adhesion programme and cell survival in epithelial cells. Nat. Cell Biol. 8:551-561.
7. Chan, W. M., W. Y. Siu, A. Lau, and R. Y. Poon. 2004. How many mutant p53 molecules are needed to inactivate a tetramer? Mol. Cell. Biol. 24:3536-3551.
8. Chang, E. C., M. Barr, Y. Wang, V. Jung, H. P. Xu, and M. H. Wigler. 1994. Cooperative interaction of S. pombe proteins required for mating and morphogenesis. Cell 79:131-141.
9. Danovi, S. A., M. Rossi, K. Gudmundsdottir, M. Yuan, G. Melino, and S. Basu. 2007. Yes-associated protein (YAP) is a critical mediator of c-Jun-dependent apoptosis. Cell Death Differ. 15:1752-1579.
10. Davison, T. S., C. Vagner, M. Kaghad, A. Ayed, D. Caput, and C. H. Arrowsmith. 1999. p73 and p63 are homotetramers capable of weak heterotypic interactions with each other but not with p53. J. Biol. Chem. 274:18709-18714.
11. Deyoung, M. P., C. M. Johannessen, C. O. Leong, W. Faquin, J. W. Rocco, and L. W. Ellisen. 2006. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. Cancer Res. 66:9362-9368.
12. Dohn, M., S. Zhang, and X. Chen. 2001. p63α and ΔNp63α can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20:3193-3205.
13. Elbashir, S. M., J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl. 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498.
14. Flores, E. R., S. Sengupta, J. B. Miller, J. J. Newman, R. Bronson, D. Crowley, A. Yang, F. McKeon, and T. Jacks. 2005. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer Cell 7:363-373.
15. Fomenkov, A., R. Zangen, Y. P. Huang, M. Osada, Z. Guo, T. Fomenkov, B. Trink, D. Sidransky, and E. A. Ratovitski. 2004. RACK1 and stratifin target ΔNp63α for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage. Cell Cycle 3:1285-1295.
16. Ghioni, P., F. Bolognese, P. H. Duijf, H. Van Bokhoven, R. Mantovani, and L. Guerrini. 2002. Complex transcriptional effects of p63 isoforms: identification of novel activation and repression domains. Mol. Cell. Biol. 22:8659-8668.
17. Gressner, O., T. Schilling, K. Lorenz, E. Schulze Schleithoff, A. Koch, H. Schulze-Bergkamen, A. Maria Lena, E. Candi, A. Terrinoni, M. Valeria Catani, M. Oren, G. Melino, P. H. Krammer, W. Stremmel, and M. Muller. 2005. TAp63α induces apoptosis by activating signaling via death receptors and mitochondria. EMBO J. 24:2458-2471.
18. Helton, E. S., J. Zhu, and X. Chen. 2006. The unique NH2-terminally deleted (DeltaN) residues, the PXXP motif, and the PPXY motif are required for the transcriptional activity of the DeltaN variant of p63. J. Biol. Chem. 281:2533-2542.
19. Hibi, K., B. Trink, M. Patturajan, W. H. Westra, O. L. Caballero, D. E. Hill, E. A. Ratovitski, J. Jen, and D. Sidransky. 2000. AIS is an oncogene amplified in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 97:5462-5467.
20. Huang, Y. P., G. Wu, Z. Guo, M. Osada, T. Fomenkov, H. L. Park, B. Trink, D. Sidransky, A. Fomenkov, and E. A. Ratovitski. 2004. Altered sumoylation of p63α contributes to the split-hand/foot malformation phenotype. Cell Cycle 3:1587-1596.
21. Ingham, R. J., K. Colwill, C. Howard, S. Dettwiler, C. S. Lim, J. Yu, K. Hersi, J. Raaijmakers, G. Gish, G. Mbamalu, L. Taylor, B. Yeung, G. Vassilovski, M. Amin, F. Chen, L. Matskova, G. Winberg, I. Ernberg, R. Linding, P. O'Donnell, A. Starostine, W. Keller, P. Metalnikov, C. Stark, and T. Pawson. 2005. WW domains provide a platform for the assembly of multiprotein networks. Mol. Cell. Biol. 25:7092-7106.
22. Jacobs, W. B., G. Govoni, D. Ho, J. K. Atwal, F. Barnabe-Heider, W. M. Keyes, A. A. Mills, F. D. Miller, and D. R. Kaplan. 2005. p63 is an essential proapoptotic protein during neural development. Neuron 48:743-756.
23. Keyes, W. M., H. Vogel, M. I. Koster, X. Guo, Y. Qi, K. M. Petherbridge, D. R. Roop, A. Bradley, and A. A. Mills. 2006. p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors. Proc. Natl. Acad. Sci. USA 103:8435-8440.
24. Keyes, W. M., Y. Wu, H. Vogel, X. Guo, S. W. Lowe, and A. A. Mills. 2005. p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev. 19:1986-1999.
25. Kraft, C., H. C. Vodermaier, S. Maurer-Stroh, F. Eisenhaber, and J. M. Peters. 2005. The WD40 propeller domain of Cdh1 functions as a destruction box receptor for APC/C substrates. Mol. Cell 18:543-553.
26. Kraus, S., D. Gioeli, T. Vomastek, V. Gordon, and M. J. Weber. 2006. Receptor for activated C kinase 1 (RACK1) and Src regulate the tyrosine phosphorylation and function of the androgen receptor. Cancer Res. 66:11047-11054.
27. Lee, H. O., J. H. Lee, E. Choi, J. Y. Seol, Y. Yun, and H. Lee. 2006. A dominant negative form of p63 inhibits apoptosis in a p53-independent manner. Biochem. Biophys. Res. Commun. 344:166-172.
28. Levy, D., Y. Adamovich, N. Reuven, and Y. Shaul. 2007. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ. 14:743-751.
29. Li, Y., Z. Zhou, and C. Chen. 2008. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis. Cell Death Differ. 15:1941-1951.
30. Liefer, K. M., M. I. Koster, X. J. Wang, A. Yang, F. McKeon, and D. R. Roop. 2000. Down-regulation of p63 is required for epidermal UV-B-induced apoptosis. Cancer Res. 60:4016-4020.
31. Liu, Y. V., J. H. Baek, H. Zhang, R. Diez, R. N. Cole, and G. L. Semenza. 2007. RACK1 competes with HSP90 for binding to HIF-1α and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1α. Mol. Cell 25:207-217.
32. Marchbank, A., L. J. Su, P. Walsh, J. DeGregori, K. Penheiter, T. B. Grayson, R. P. Dellavalle, and L. A. Lee. 2003. The CUSP ΔNp63α isoform of human p63 is downregulated by solar-simulated ultraviolet radiation. J. Dermatol. Sci. 32:71-74.
33. Matheny, K. E., C. E. Barbieri, J. C. Sniezek, C. L. Arteaga, and J. A. Pietenpol. 2003. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells. Laryngoscope 113:936-939.
34. McCahill, A., J. Warwicker, G. B. Bolger, M. D. Houslay, and S. J. Yarwood. 2002. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol. Pharmacol. 62:1261-1273.
35. McKeon, F. 2004. p63 and the epithelial stem cell: more than status quo? Genes Dev. 18:465-469.
36. Mills, A. A. 2006. p63: oncogene or tumor suppressor? Curr. Opin. Genet. Dev. 16:38-44.
37. Mills, A. A., B. Zheng, X. J. Wang, H. Vogel, D. R. Roop, and A. Bradley. 1999. p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713.
38. Min, J., S. Okada, M. Kanzaki, J. S. Elmendorf, K. J. Coker, B. P. Ceresa, L. J. Syu, Y. Noda, A. R. Saltiel, and J. E. Pessin. 1999. Synip: a novel insulin-regulated syntaxin 4-binding protein mediating GLUT4 translocation in adipocytes. Mol. Cell 3:751-760.
39. Nguyen, B. C., K. Lefort, A. Mandinova, D. Antonini, V. Devgan, G. Della Gatta, M. I. Koster, Z. Zhang, J. Wang, A. Tommasi di Vignano, J. Kitajewski, G. Chiorino, D. R. Roop, C. Missero, and G. P. Dotto. 2006. Cross-regulation between Notch and p63 in keratinocyte commitment to differentiation. Genes Dev. 20:1028-1042.
40. Osada, M., M. Ohba, C. Kawahara, C. Ishioka, R. Kanamaru, I. Katoh, Y. Ikawa, Y. Nimura, A. Nakagawara, M. Obinata, and S. Ikawa. 1998. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat. Med. 4:839-843.
41. Ozaki, T., K. Watanabe, T. Nakagawa, K. Miyazaki, M. Takahashi, and A. Nakagawara. 2003. Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB. Oncogene 22:3231-3242.
42. Patturajan, M., S. Nomoto, M. Sommer, A. Fomenkov, K. Hibi, R. Zangen, N. Poliak, J. Califano, B. Trink, E. Ratovitski, and D. Sidransky. 2002. ΔNp63 induces beta-catenin nuclear accumulation and signaling. Cancer Cell 1:369-379.
43. Pellegrini, G., E. Dellambra, O. Golisano, E. Martinelli, I. Fantozzi, S. Bondanza, D. Ponzin, F. McKeon, and M. De Luca. 2001. p63 identifies keratinocyte stem cells. Proc. Natl. Acad. Sci. USA 98:3156-3161.
44. Perez-Losada, J., D. Wu, R. DelRosario, A. Balmain, and J. H. Mao. 2005. p63 and p73 do not contribute to p53-mediated lymphoma suppressor activity in vivo. Oncogene 24:5521-5524.
45. Rocco, J. W., C. O. Leong, N. Kuperwasser, M. P. DeYoung, and L. W. Ellisen. 2006. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9:45-56.
46. Rossi, M., R. I. Aqeilan, M. Neale, E. Candi, P. Salomoni, R. A. Knight, C. M. Croce, and G. Melino. 2006. The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc. Natl. Acad. Sci. USA 103:12753-12758.
47. Rossi, M., V. De Laurenzi, E. Munarriz, D. R. Green, Y. C. Liu, K. H. Vousden, G. Cesareni, and G. Melino. 2005. The ubiquitin-protein ligase Itch regulates p73 stability. EMBO J. 24:836-848.
48. Rossi, M., M. De Simone, A. Pollice, R. Santoro, G. La Mantia, L. Guerrini, and V. Calabro. 2006. Itch/AIP4 associates with and promotes p63 protein degradation. Cell Cycle 5:1816-1822.
49. Senoo, M., F. Pinto, C. P. Crum, and F. McKeon. 2007. p63 is essential for the proliferative potential of stem cells in stratified epithelia. Cell 129:523-536.
50. Strano, S., E. Munarriz, M. Rossi, L. Castagnoli, Y. Shaul, A. Sacchi, M. Oren, M. Sudol, G. Cesareni, and G. Blandino. 2001. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem. 276:15164-15173.
51. Suh, E. K., A. Yang, A. Kettenbach, C. Bamberger, A. H. Michaelis, Z. Zhu, J. A. Elvin, R. T. Bronson, C. P. Crum, and F. McKeon. 2006. p63 protects the female germ line during meiotic arrest. Nature 444:624-628.
52. Truong, A. B., M. Kretz, T. W. Ridky, R. Kimmel, and P. A. Khavari. 2006. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 20:3185-3197.
53. Urist, M., T. Tanaka, M. V. Poyurovsky, and C. Prives. 2004. p73 induction after DNA damage is regulated by checkpoint kinases Chk1 and Chk2. Genes Dev. 18:3041-3054.
54. Urist, M. J., C. J. Di Como, M. L. Lu, E. Charytonowicz, D. Verbel, C. P. Crum, T. A. Ince, F. D. McKeon, and C. Cordon-Cardo. 2002. Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol. 161:1199-1206.
55. Vojtek, A. B., S. M. Hollenberg, and J. A. Cooper. 1993. Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74:205-214.
56. Westfall, M. D., A. S. Joyner, C. E. Barbieri, M. Livingstone, and J. A. Pietenpol. 2005. Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of ΔNp63α. Cell Cycle 4:710-716.
57. Westfall, M. D., D. J. Mays, J. C. Sniezek, and J. A. Pietenpol. 2003. The ΔNp63α phosphoprotein binds the p21 and 14-3-3 promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations. Mol. Cell. Biol. 23:2264-2276.
58. Winberg, G., L. Matskova, F. Chen, P. Plant, D. Rotin, G. Gish, R. Ingham, I. Ernberg, and T. Pawson. 2000. Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases. Mol. Cell. Biol. 20:8526-8535.
59. Wu, G., S. Nomoto, M. O. Hoque, T. Dracheva, M. Osada, C. C. Lee, S. M. Dong, Z. Guo, N. Benoit, Y. Cohen, P. Rechthand, J. Califano, C. S. Moon, E. Ratovitski, J. Jen, D. Sidransky, and B. Trink. 2003. ΔNp63α and TAp63α regulate transcription of genes with distinct biological functions in cancer and development. Cancer Res. 63:2351-2357.
60. Wu, G., M. Osada, Z. Guo, A. Fomenkov, S. Begum, M. Zhao, S. Upadhyay, M. Xing, F. Wu, C. Moon, W. H. Westra, W. M. Koch, R. Mantovani, J. A. Califano, E. Ratovitski, D. Sidransky, and B. Trink. 2005. ΔNp63α upregulates the Hsp70 gene in human cancer. Cancer Res. 65:758-766.
61. Yang, A., M. Kaghad, D. Caput, and F. McKeon. 2002. On the shoulders of giants: p63, p73 and the rise of p53. Trends Genet. 18:90-95.
62. Yang, A., M. Kaghad, Y. Wang, E. Gillett, M. D. Fleming, V. Dotsch, N. C. Andrews, D. Caput, and F. McKeon. 1998. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2:305-316.
63. Yang, A., R. Schweitzer, D. Sun, M. Kaghad, N. Walker, R. T. Bronson, C. Tabin, A. Sharpe, D. Caput, C. Crum, and F. McKeon. 1999. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-718.
64. Yu, H. 2007. Cdc20: a WD40 activator for a cell cycle degradation machine. Mol. Cell 27:3-16.
65. Zupnick, A., and C. Prives. 2006. Mutational analysis of the p53 core domain L1 loop. J. Biol. Chem. 281:20464-20473.